Jeffrey Hubbell to Recombinant Fusion Proteins
This is a "connection" page, showing publications Jeffrey Hubbell has written about Recombinant Fusion Proteins.
Connection Strength
1.813
-
Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models. Arthritis Rheumatol. 2021 05; 73(5):769-778.
Score: 0.659
-
Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nat Biomed Eng. 2021 05; 5(5):387-398.
Score: 0.641
-
Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 2001 May; 15(7):1300-2.
Score: 0.166
-
Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control. Front Immunol. 2019; 10:294.
Score: 0.143
-
The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials. 2013 Aug; 34(24):5958-68.
Score: 0.096
-
Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng. 2005 Feb 05; 89(3):253-62.
Score: 0.054
-
Covalently conjugated VEGF--fibrin matrices for endothelialization. J Control Release. 2001 May 14; 72(1-3):101-13.
Score: 0.042
-
Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004 Apr 30; 94(8):1124-32.
Score: 0.013